Publication

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

Related publications (81)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

Graph Chatbot

Chat with Graph Search

TGF beta-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression

The role of eosinophils in breast cancer

Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation

Mechanical Immunoengineering of T Cells for Enhanced Cancer Immunotherapy

Immunosuppressive roles of Activin-A in melanoma and characterization of its precursor cleavage

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence

An autonomous microfluidic device for identification and analysis of individual clinically-relevant mammalian cells

Intraductal xenografts model estrogen receptor-positive (ER+) breast cancer dormancy and reveal a critical role for epithelial-mesenchymal transition (EMT) in its establishment

Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1